{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:23:55Z","timestamp":1792614235524,"version":"4.5.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T00:00:00Z","timestamp":1354060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050237","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T21:55:47Z","timestamp":1354139747000},"page":"e50237","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Edina","family":"Silajd\u017ei\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"K Blennow","year":"2006","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer's disease","volume":"461","author":"RJ Perrin","year":"2009","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pneurobio.2010.11.005","article-title":"Biomarkers for Alzheimer's disease therapeutic trials","volume":"95","author":"H Hampel","year":"2012","journal-title":"Prog Neurobiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"D Harold","year":"2009","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"JC Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"S Seshadri","year":"2010","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1006\/bbrc.1994.2580","article-title":"Purification and characterization of brain clusterin","volume":"204","author":"T Oda","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","article-title":"Clusterin: a forgotten player in Alzheimer's disease","volume":"61","author":"T Nuutinen","year":"2009","journal-title":"Brain Res Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/intimm\/1.5.551","article-title":"SP-40,40 is an inhibitor of C5b-6-initiated haemolysis","volume":"1989:1","author":"BF Murphy","year":"1989","journal-title":"Int Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1021\/bi962895r","article-title":"Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization","volume":"36","author":"JF McDonald","year":"1997","journal-title":"Biochemistry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1242\/jcs.110.14.1635","article-title":"Clusterin\/ApoJ expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse","volume":"110","author":"D Michel","year":"1997","journal-title":"J Cell Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1530-0277.2011.01588.x","article-title":"Nuclear clusterin is associated with neuronal apoptosis in the developing rat brain upon ethanol exposure","volume":"36","author":"N Kim","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/bi00474a025","article-title":"Apolipoprotein J: structure and tissue distribution","volume":"29","author":"HV de Silva","year":"1990","journal-title":"Biochemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"EM Schrijvers","year":"2011","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-2011-111844","article-title":"Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease","volume":"29","author":"YY Xing","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"M Thambisetty","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","article-title":"Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment","volume":"59","author":"M Thambisetty","year":"2012","journal-title":"Neuroimage"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/jama.2011.713","article-title":"Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses","volume":"305","author":"JP Ioannidis","year":"2011","journal-title":"JAMA"},{"key":"ref20","unstructured":"Association AP (1987) Diagnostic and Statistical Manual of Mental Disorders. 3rd, revised ed. Washington DC: American Psychiatric Association."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"GC Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"ref23","first-page":"23","article-title":"Research criteria for subcortical vascular dementia in clinical trials","volume":"Suppl 59","author":"T Erkinjuntti","year":"2000","journal-title":"J Neural Transm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.53.5.902","article-title":"Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies","volume":"53","author":"IG McKeith","year":"1999","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease","volume":"58","author":"GM McKhann","year":"2001","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/pr100805h","article-title":"Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction","volume":"10","author":"J Cubedo","year":"2011","journal-title":"J Proteome Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2011-110251","article-title":"Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration","volume":"25","author":"B Sch\u00fcrmann","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"O Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"LM Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/pr101221h","article-title":"Serum clusterin levels are not increased in presymptomatic Alzheimer's disease","volume":"10","author":"L IJsselstijn","year":"2011","journal-title":"J Proteome Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"CL Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","article-title":"Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression","volume":"35","author":"M Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"M Maes","year":"1997","journal-title":"Psychiatry Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3999(97)00139-6","article-title":"Acute phase proteins in major depression","volume":"43","author":"M Berk","year":"1997","journal-title":"J Psychosom Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T13:47:56Z","timestamp":1643723276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050237"}},"subtitle":[],"editor":[{"given":"Gianluigi","family":"Forloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050237","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}